Stifel Financial Corp lessened its stake in Nutrien Ltd. (NYSE:NTR - Free Report) by 9.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 224,118 shares of the company's stock after selling 24,760 shares during the quarter. Stifel Financial Corp's holdings in Nutrien were worth $10,029,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of NTR. Uncommon Cents Investing LLC boosted its stake in Nutrien by 2.1% during the 4th quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company's stock valued at $517,000 after purchasing an additional 235 shares during the period. Rhumbline Advisers increased its position in Nutrien by 3.5% in the 4th quarter. Rhumbline Advisers now owns 7,398 shares of the company's stock worth $331,000 after buying an additional 247 shares during the period. FFT Wealth Management LLC lifted its holdings in shares of Nutrien by 0.9% during the fourth quarter. FFT Wealth Management LLC now owns 29,732 shares of the company's stock worth $1,330,000 after buying an additional 277 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Nutrien by 23.9% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,804 shares of the company's stock valued at $81,000 after acquiring an additional 348 shares during the period. Finally, PFG Investments LLC grew its stake in shares of Nutrien by 2.0% in the fourth quarter. PFG Investments LLC now owns 20,097 shares of the company's stock worth $899,000 after acquiring an additional 386 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company's stock.
Nutrien Price Performance
Shares of Nutrien stock traded up $0.30 during trading on Wednesday, reaching $57.11. The company's stock had a trading volume of 3,357,655 shares, compared to its average volume of 2,114,086. Nutrien Ltd. has a one year low of $43.70 and a one year high of $60.87. The stock has a 50-day moving average price of $51.26 and a two-hundred day moving average price of $49.50. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $27.88 billion, a P/E ratio of 41.69, a price-to-earnings-growth ratio of 1.19 and a beta of 0.77.
Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). The company had revenue of $5.08 billion during the quarter, compared to analyst estimates of $5.09 billion. Nutrien had a net margin of 2.62% and a return on equity of 6.81%. As a group, sell-side analysts anticipate that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.
Nutrien Cuts Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, April 10th. Stockholders of record on Monday, March 31st were paid a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 3.82%. The ex-dividend date of this dividend was Monday, March 31st. Nutrien's dividend payout ratio (DPR) is presently 159.12%.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the stock. CIBC increased their price target on shares of Nutrien from $64.00 to $66.00 and gave the company an "outperformer" rating in a report on Tuesday, February 25th. UBS Group lowered their price target on Nutrien from $54.00 to $52.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 16th. Royal Bank of Canada reissued an "outperform" rating and set a $60.00 price objective on shares of Nutrien in a report on Monday, February 24th. Berenberg Bank raised their target price on Nutrien from $54.00 to $59.00 and gave the stock a "buy" rating in a research report on Tuesday, April 15th. Finally, BNP Paribas upgraded shares of Nutrien to a "strong-buy" rating in a research note on Wednesday, April 9th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $59.27.
Get Our Latest Stock Report on NTR
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Articles

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.